跳至主要内容
临床试验/NCT02244671
NCT02244671已完成不适用

Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)

Fox, Donald Munro, M.D., P.C.1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6
试验地点
1
主要终点
Orbital volume

研究概览

简要总结

immobilization of yoked extra-ocular muscles in the anophthalmic orbit, in conjunction with platelet-rich-plasma, will improve integration of viable adipocytes injected into orbital fat

详细描述

Immobilization of tissue (graft, graft bed) is a prerequisite for tissue integration. Since yoked extra-ocular muscles continue to be stimulated by movements of the seeing eye after fat injection into the anophthalmic orbit, the use of botulinum toxin(s) can be used to prevent movement of the orbital tissue bed(s) and improve anchoring of injected fat. Platelet rich plasma may also improve fat cell anchoring by the action of fibrin on the adhesion process. This innovation builds on the results of IRB protocols 10.27 and 12.01 as registered with Clinical Trials.gov

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • anophthalmic enophthalmos in subjects within a 50 mile radius of New York City, grade 0-1 anesthesia risk, ages 21-75

排除标准

  • radiated orbits

研究组 & 干预措施

fat, PRP, botulinum toxin

Experimental

Fat injection with platelet-rich-plasma (PRP) after immobilizing the extraocular muscles with botulinum toxin

干预措施: fat, PRP, botulinum toxin (Procedure)

fat, PRP, botulinum toxin

Experimental

Fat injection with platelet-rich-plasma (PRP) after immobilizing the extraocular muscles with botulinum toxin

干预措施: botulinum toxin (Drug)

fat, PRP, botulinum toxin

Experimental

Fat injection with platelet-rich-plasma (PRP) after immobilizing the extraocular muscles with botulinum toxin

干预措施: PRP (Device)

结局指标

主要结局

Orbital volume

时间窗: one year

Augmentation of orbital volume accessed with clinical photographs and non-contrast MRI

次要结局

未报告次要终点

研究者

发起方
Fox, Donald Munro, M.D., P.C.
申办方类型
Indiv
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验